News

The SEC's proposed rules provide long-awaited regulatory clarity on how investment advisers and funds can legally hold cryptocurrency assets, removing a major compliance barrier that has constrained institutional adoption. The framework permitting state-regulated custodians and self-custody under specific conditions legitimises crypto holdings in professional portfolios and could accelerate institutional inflows into digital assets. For Australian investors, this US regulatory development matters because many ASX-listed fintech and crypto-exposed companies operate in both markets; clearer US rules reduce compliance risk and improve the investment case for platforms offering crypto services across jurisdictions.

The U.S. SEC has proposed new custody rules for digital assets, signalling regulatory clarity on how crypto assets should be safeguarded—a key step toward mainstream institutional adoption. This moves the needle on the SEC's broader digital assets framework, reducing uncertainty that's plagued the sector since FTX collapsed. For Australian investors, clearer U.S. crypto custody rules could accelerate local demand for regulated crypto platforms and ETFs; watch the ASX and ASIC's response, as Australia typically aligns with major regulatory shifts.

Lyft's $272.5m California settlement over wage theft claims represents a major regulatory win for workers' rights and signals intensifying pressure on gig economy labour practices. The settlement—California's largest wage theft case—requires Lyft to pay $237m directly to drivers, validating arguments that independent contractor classification unfairly avoided employment benefits and protections. This sets a precedent that could ripple across the US and internationally (including Australia), threatening the business model of Lyft, Uber, and similar platforms; investors should monitor whether similar lawsuits succeed and whether platforms lobby for legislative carve-outs, as this directly impacts profitability and operating leverage.

The RBA's surcharge reforms, intended to protect consumers by capping payment processing fees retailers can pass on, are backfiring with retailers claiming they'll compensate by raising base prices across the board. This creates a potential inflationary pressure point—if widespread, it could offset consumer savings and complicate the RBA's inflation management heading into 2025. Investors should watch whether retailers actually implement broad price hikes and whether the ACCC moves to address workaround tactics, as this will signal whether the policy achieves its intended benefit or simply shifts costs in unhelpful ways.

The Climate Change Authority chair Matt Kean has publicly criticized NSW's approval of the Hunter Valley Operations coal mine expansion—the largest in state history—citing inadequate consideration of climate-related economic costs in the planning process. This reflects growing tension between Australia's climate commitments and coal sector expansion, and signals potential future regulatory friction for coal operators. For ASX investors, this underscores the political and policy headwinds facing thermal coal companies and raises questions about long-term viability of coal projects; while today's approval stands, expect continued pressure from federal climate policy and potential intervention as Labor seeks to reconcile mining jobs with net-zero targets.

Anthropic is lobbying the Australian government for an opt-out model allowing AI companies to train on copyrighted Australian content, marking a significant policy pivot after failing to secure blanket copyright exemptions. The ABC and SBS are pushing back hard, warning of 'cannibalisation' of news and demanding regulatory protections and compensation for media organisations—a clash that will shape how Australian content is used by AI systems. This regulatory battle is crucial for Australian media companies and investors; the outcome will determine whether news publishers can protect their intellectual property or face devaluation as AI training data, with potential implications for media sector valuations and ad revenue models.

A US Senate tax proposal would exempt dollar-stablecoin transactions from capital gains reporting, while Bitcoin remains subject to disposition tracking on IRS forms. This creates a practical advantage for stablecoin use in everyday commerce by removing tax friction, which could accelerate stablecoin adoption for payments while leaving Bitcoin investors with ongoing compliance burden. Australian investors should note this reflects growing US regulatory differentiation between stablecoins and decentralized crypto—if Australia follows suit, it could reshape how cryptoassets are taxed domestically and influence which tokens gain mainstream adoption for transactions versus holdings.

EU regulators are investigating whether Binance is exploiting a loophole in MiCA (Markets in Crypto-Assets) rules that allows certain exemptions for crypto service providers. ESMA, the EU's markets authority, is pushing for tighter enforcement powers to close gaps in crypto regulation. This matters because Binance is Europe's largest crypto exchange by volume—any enforcement action could disrupt services or force costly compliance changes, rippling across the broader crypto market and affecting Australian investors exposed to crypto assets or Binance's native token (BNB). Watch for ESMA's formal guidance or enforcement actions in coming months, which could set a precedent for other regulators globally, including ASIC.

EU regulators are investigating how Binance continues operating in the bloc via a 'reverse solicitation' loophole after losing MiCA (Markets in Crypto-Assets) registrations, suggesting the exchange may be circumventing compliance requirements. This reflects escalating regulatory scrutiny of crypto exchanges globally and could signal tighter enforcement frameworks ahead. For Australian investors and crypto operators, this illustrates how regulators across major jurisdictions are cracking down on workarounds—Australia's ASIC has similarly tightened crypto licensing standards, making compliant platforms more important but potentially reducing retail access to certain services.

Long Shortz Optiscan has submitted its InForm digital pathology device to the US FDA via the 510(k) pathway, a significant regulatory milestone that clears the way for potential US market entry. The 510(k) process is typically faster than full premarket approval, suggesting commercialisation could happen within 12–18 months if approved. For Australian investors, this de-risks the company's international growth strategy and opens access to a vastly larger market; success here could materially improve revenues and justify higher valuations, though execution risk remains until approval is confirmed.

Optiscan has achieved a significant regulatory milestone by securing FDA acceptance of its InForm digital pathology platform for formal review—moving from development into the agency's formal assessment process. This is a positive step for commercialising the technology in the US market, though approval is not guaranteed and typically takes 12-24 months. For Australian investors, this validates the company's technology and opens a major revenue pathway if cleared, though near-term earnings impact depends on FDA decision timing and eventual market uptake.

The ATO has released data showing major multinationals including Microsoft, Netflix, and Singtel generated substantial Australian revenues while paying little to no corporate income tax, likely through legitimate structures like depreciation, debt deductions, and transfer pricing. This reinforces ongoing debate about tax efficiency by foreign tech and telecom giants operating in Australia, though the ATO notes these arrangements may be legally compliant. The disclosure could prompt renewed pressure on the government to tighten tax rules, particularly around intangible assets and profit-shifting, which could eventually affect the cost structure of these businesses if policy changes.

The US Commodity Futures Trading Commission (CFTC) is attempting to reclassify event contracts—bets on real-world outcomes like elections or sports results—as 'swaps' under existing financial regulations. This move would give the CFTC exclusive jurisdiction over prediction markets, potentially restricting how platforms like Polymarket operate and who can trade on them. For Australian investors, this signals regulatory tightening around speculative trading platforms globally; while Australia's own prediction market rules remain unclear, CFTC actions often influence how international brokers and fintech platforms treat Australian clients.

The SEC has charged an investment firm with defrauding investors in funds holding pre-IPO stakes, including SpaceX positions. This regulatory action signals heightened scrutiny of private markets intermediaries and the valuation practices used in pre-IPO fund vehicles, which have proliferated as an alternative investment class. While it doesn't directly impact listed companies, Australian investors with exposure to private equity funds or alternative investment platforms should be aware this could lead to broader regulatory tightening and increased due diligence requirements for private market investments.

Union leaders and academics are pushing for a levy on big tech companies operating Australian data centres to fund domestic AI development—a proposal that sits at the intersection of industrial policy and technology regulation. This signals growing momentum for Australian governments to extract economic value from tech infrastructure investment while building local AI capabilities. Key watch: whether federal or state governments pick up the proposal, as a levy could affect capex economics for hyperscalers like Google, Microsoft, and Meta planning Australian expansions, and potentially influence where they locate future data centre investments.

Eli Lilly is launching LillyDirect, a direct-to-consumer platform for dispensing GLP-1 drugs like Mounjaro, bypassing traditional pharmacies and doctors. This move has drawn criticism from healthcare professionals who argue it mirrors problematic US practices and raises concerns about medical supervision and pharmacy margins. For Australian investors, this signals Lilly's aggressive push into DTC channels globally—potentially pressuring traditional pharmacy networks and regulatory bodies here to respond, while the efficiency gains may support Lilly's earnings growth in high-demand GLP-1 markets.

The US CFTC is pushing new regulatory rules to classify event contracts as 'swaps' under federal jurisdiction, seeking to block state-level gambling challenges against prediction-market operators. This move could reshape the legal landscape for platforms like Polymarket by centralising oversight but may also restrict market access and impose stricter compliance requirements. For Australian investors, this signals growing regulatory friction around crypto-adjacent trading platforms globally—watch whether ASIC follows suit with its own prediction market framework, and note that US regulatory uncertainty could delay Australian fintech expansion into derivatives betting.

The FTC has launched an industry-wide investigation into major AI labs including OpenAI and Anthropic, marking the first formal US enforcement action targeting potential risks from autonomous AI systems. This regulatory scrutiny reflects growing concerns about safety and control of AI agents following reported incidents mid-year, and signals that policymakers are moving beyond passive oversight toward active enforcement. For Australian investors, this matters because it could tighten compliance requirements for AI companies (affecting tech exposure in both ASX and US portfolios) and may slow product deployment timelines, though it's unlikely to derail the sector fundamentally—rather, it establishes the regulatory guardrails the industry will operate within going forward.

The US White House is considering new CFTC (Commodity Futures Trading Commission) rules to govern prediction markets, signalling an intensifying regulatory push over a fast-growing sector. Prediction markets like PredictIt and Polymarket have exploded in popularity, but their regulatory status remains murky—sitting in limbo between the CFTC, SEC, and state gambling regulators. The outcome could reshape how these platforms operate in the US and abroad. Australian investors should watch this closely: if the US tightens rules, it may spark a domino effect globally, affecting Australian-accessible platforms and fintech companies with exposure to prediction market infrastructure.

The Federal Reserve has finalized modifications to its annual stress testing framework for large banks. While the specifics aren't detailed in this headline, stress test changes typically affect how much capital banks must hold and their ability to return funds to shareholders—directly influencing dividend policies and lending capacity. For Australian investors, US banking stress tests matter because they set capital standards for global financial institutions and can influence cross-border lending conditions; changes that tighten requirements may slow credit growth, while looser standards could support market risk appetite.